Indices of initial hepatitis C virus RNA reduction rate to predict efficacy of interferon-beta followed by peginterferon plus ribavirin for genotype 1b high viral load-Reference-Cited by-同舟云学术

Indices of initial hepatitis C virus RNA reduction rate to predict efficacy of interferon-beta followed by peginterferon plus ribavirin for genotype 1b high viral load

Published:2013-07-11 Issue:7 Volume:44 Page:728-734
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Okushin Hiroaki¹,Yamamoto Takeharu¹,Kishida Hiroshi¹,Morii Kazuhiko¹,Uesaka Koichi¹

Affiliation:

1. Department of Internal Medicine; Himeji Red Cross Hospital; Himeji-shi Hyogo Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12182/fullpdf

Reference41 articles.

1. Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis;Cardoso;J Hepatol,2010

2. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis;Ikeda;Hepatology,1999

3. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group;Kasahara;Hepatology,1998

4. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy;Yoshida;Ann Intern Med,1999

5. HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy;Hayes;Gut,2011